New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
07:26 EDTGMED, WMGI, SNN, NUVA, MDTOrtho consolidation likely in 'early innings,' says Leerink
Leerink says consolidation in the ortho space is likely in the "early innings" after reports surfaced that Medtronic (MDT) is considering a bid for Smith & Nephew (SNN). The firm views Smith & Nephew's product portfolio as "highly complementary" to Medtronic, and estimates the potential deal would be meaningfully dilutive in year one and likely neutral to accretive thereafter. Leerink notes that recent Smith & Nephew takeover reports have pressured small cap names in the space, namely Globus Medical (GMED), NuVasive (NUVA) and Wright Medical (WMGI), all of which are considered potential acquisition targets. The firm expects the large deals to get done first, with attention then turning to small-to-mid sized acquisitions. It reiterates Outperform ratings on Globus, NuVasive and NuVasive.
News For MDT;SNN;GMED;NUVA;WMGI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
February 26, 2015
12:15 EDTNUVANuVasive management to meet with Piper Jaffray
Meetings to be held in New York on March 3 and in Denver on March 4 hosted by Piper Jaffray.
February 25, 2015
17:50 EDTWMGIWright Medical sees FY15 adjusted EPS ($1.67)-($1.77), consensus (95c)
Subscribe for More Information
17:48 EDTWMGIWright Medical reports Q4 adjusted EPS (25c), consensus (27c)
Reports Q4 revenue $83.3M, consensus $84.01M.
16:22 EDTGMEDGlobus Medical enters agreement to acquire Branch Medical Group
Subscribe for More Information
16:21 EDTGMEDGlobus Medical backs FY15 EPS view about $1.01, consensus $1.02
Backs FY15 revenue view about $510M, consensus $512.92M.
16:20 EDTGMEDGlobus Medical reports Q4 adjusted EPS 30c, consensus 25c
Subscribe for More Information
February 24, 2015
16:30 EDTNUVANuVasive announces updated Non-GAAP definition
NuVasive announced that it will implement an updated non-GAAP definition in Q1. NuVasive will redefine its non-GAAP cost of goods sold, gross margin, operating expenses, operating margin and earnings per share financial measures from its existing non-GAAP definition to include the impact of non-cash stock-based compensation and certain intellectual property related litigation expenses, both of which had previously been excluded in the company's calculation of these non-GAAP financial measures. In addition to GAAP results, these non-GAAP measures are intended to provide additional information to enable investors to assess the Company's operations in the same way management assesses operations. Management uses non-GAAP measures to budget, evaluate and measure the company's performance and sees these results as an indicator of the company's ongoing business performance. The company believes these changes in non-GAAP reporting increase transparency and better reflect the underlying financial performance of the business. CFO Quentin Blackford said, "This update allows us to provide investors with a meaningful non-GAAP measurement that represents the performance of our core business on a more inclusive, comprehensive basis. Importantly, this change does not impact NuVasive's plan to deliver at least 100 basis points of operating margin expansion each year, as well as improved EBITDA margins for the next several years as we rapidly scale the business in the U.S. and internationally and capture well-identified opportunities to drive profitability."
16:18 EDTNUVANuVasive sees FY15 adjusted EPS approximately $1.10, consensus $1.53
Sees FY15 revenue approximately $810M, consensus $811.03M, which includes an approximate $10M of currency headwinds.
16:16 EDTNUVANuVasive reports Q4 adjusted EPS 39c, consensus 37c
Reports Q4 revenue $204.3M, consensus $201.39M.
13:02 EDTMDTMedtronic confirms FDA approval of VenaSeal closure system
Subscribe for More Information
February 23, 2015
08:40 EDTMDTMedtronic acquires Advanced Uro-Solutions, terms not disclosed
Medtronic announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee. Terms of the acquisition agreement, which closed in December 2014, were not disclosed.
February 20, 2015
12:19 EDTMDTFDA approves closure system to permanently treat varicose veins
Subscribe for More Information
February 19, 2015
16:15 EDTMDTMedtronic SANTE trial data show sustained safety, improvements in QOLIE-31
Subscribe for More Information
February 17, 2015
09:29 EDTMDTMedtronic says FY16 constant currency revenue may be up mid-single digit range
Subscribe for More Information
09:27 EDTMDTMedtronic, Covidien targeting over $850M in cost synergies through FY18
Subscribe for More Information
08:49 EDTMDTMedtronic sees being at high end of Q4 revenue growth range
Subscribe for More Information
07:19 EDTMDTMedtronic sees Q4 revenue up 4%-6%
Subscribe for More Information
07:18 EDTMDTMedtronic reports Q3 EPS $1.01, consensus 97c
Subscribe for More Information
February 16, 2015
13:59 EDTMDTMedtronic receives expanded indications of the Vertex Reconstruction System
Subscribe for More Information
12:30 EDTMDTMedtronic announces CE mark, European launch of the Euphora catheter
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use